Back
Aclaris Therapeutics, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Buy
55
ACRS
Aclaris Therapeutics, Inc.
Last Price:
$3.50
Seasonality Move:
26.08%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowAclaris Therapeutics, Inc. Stock Forecast
-
Is Aclaris Therapeutics, Inc. Stock Undervalued?The current Aclaris Therapeutics, Inc. [ACRS] share price is $3.51. The Score for ACRS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ACRS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Aclaris Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Aclaris Therapeutics, Inc. Stock Rating
Data Unavailable
Aclaris Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aclaristx.com
52-Week Data
52-Week High:
4.89
52-Week Low:
1.05
Prediction Charts
Market Cap:
380.3M
Price in USD:
3.51
Volume:
1.6M
Beta:
0.75
Technical Analysis
SMA50:
3.01
SMA100:
2.54
SMA200:
2.01
52-Wk Change:
46.86%
Stock Predictions
-
Is Aclaris Therapeutics, Inc. stock public?Yes, Aclaris Therapeutics, Inc. is a publicly traded company.
-
What is the Aclaris Therapeutics, Inc. stock quote today?The Aclaris Therapeutics, Inc. stock price is 3.51 USD today.
-
How to buy Aclaris Therapeutics, Inc. stock online?You can buy Aclaris Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-8 | 2.65 | 2.68 | 2.69 | 2.59 |
| Jan-9 | 2.68 | 2.64 | 2.74 | 2.63 |
| Jan-12 | 2.61 | 2.66 | 2.68 | 2.50 |
| Jan-13 | 2.64 | 2.71 | 2.74 | 2.59 |
| Jan-14 | 2.72 | 2.74 | 2.81 | 2.70 |
| Jan-15 | 2.75 | 2.67 | 2.77 | 2.64 |
| Jan-16 | 2.69 | 2.62 | 2.69 | 2.61 |
| Jan-20 | 2.95 | 4.43 | 4.89 | 2.95 |
| Jan-21 | 4.24 | 4.42 | 4.80 | 4.03 |
| Jan-22 | 4.46 | 4.53 | 4.69 | 4.14 |
| Jan-23 | 4.52 | 4.50 | 4.84 | 4.39 |
| Jan-26 | 4.52 | 3.82 | 4.57 | 3.71 |
| Jan-27 | 3.84 | 3.87 | 3.99 | 3.78 |
| Jan-28 | 3.90 | 3.51 | 3.92 | 3.51 |
Aclaris Therapeutics, Inc. Earnings
Data Unavailable
Aclaris Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.25 per share.
* Aclaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.